A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors

Clinical trial NCT06452160 · RECRUITING

Trial details

NCT number: NCT06452160
Sponsor: BridGene Biosciences Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Mesothelioma Epithelioid Hemangioendothelioma(EHE)Solid Tumor

Start date: 2024-06-27
Primary completion: 2027-06-01
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.